Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Food: An Open-Label, Randomized, Parallel Group Phase 4 Study of the Efficacy and Safety of Patiromer for Oral Suspension With or Without Food for the Treatment of Hyperkalemia (TOURMALINE)

NCT02694744 is registered in ClinicalTrials.gov with Relypsa, Inc. as lead sponsor.

NCT NCT02694744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02694744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Food: An Open-Label, Randomized, Parallel Group Phase 4 Study of the Efficacy and Safety of Patiromer for Oral Suspension With or Without Food for the Treatment of Hyperkalemia (TOURMALINE)
Lead sponsor
Relypsa, Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2016
Completion date
August 31, 2016
Enrollment
114 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia